Skip to main content

Advertisement

SpringerLink
Log in

Role of anti-infective strategies in the prevention of stroke

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Case-control studies and a few prospective studies have indicated that chronic infections may add to the risk of stroke and that acute infections may act as trigger factors for stroke. Such chronic infections include periodontal disease, infection with Chlamydia pneumoniae or Helicobacter pylori, and chronic bronchitis. A causal role of these infectious diseases has not been proved, given conflicting study results, possible residual confounding in observational studies, and the lack of evidence from interventional trials. Therefore, special treatment regimens for stroke prevention based on serologic or genomic evidence of infection are not indicated outside of randomized studies at present. However, the preliminary available evidence suggests that in patients with previous cerebral ischemia, clinically diagnosed chronic infections should be taken seriously and should receive the treatment that is indicated according to current guidelines. This may include appropriate treatment of moderate or severe periodontitis and of chronic bronchitis. Inflammatory parameters (eg, C-reactive protein, leukocyte count, fibrinogen) are independently associated with the risk of first or recurrent stroke. The question of whether these indexes are causally related to stroke or merely represent risk markers is not sufficiently clarified. Their use in monitoring individual risk in daily clinical practice is limited at present by the lack of clearly defined therapeutic strategies to modify these parameters, although statins and other drugs can influence inflammatory markers. Observational studies have shown that influenza vaccination is significantly and independently associated with a reduced risk of stroke and myocardial infarction. Although interventional studies in stroke are lacking, it is recommendable that in accordance with current guidelines patients with previous vascular disease, including stroke, patients with high risk of stroke, and all subjects above age 60, receive an influenza vaccination annually.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gorelick PB: Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke 2002, 33:862–875.

    Article  PubMed  Google Scholar 

  2. Chiu B: Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999, 138:S534-S546.

    Article  PubMed  CAS  Google Scholar 

  3. Desvarieux M, Demmer RT, Rundek T, et al.: Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke 2003, 34:2120–2125.

    Article  PubMed  Google Scholar 

  4. Desvarieux M, Schwahn C, Volzke H, et al.: Gender differences in the relationship between periodontal disease, tooth loss, and atherosclerosis. Stroke 2004, 35:2029–2035.

    Article  PubMed  Google Scholar 

  5. Grau AJ, Becher H, Ziegler CM, et al.: Periodontal disease as a risk factor for ischemic stroke. Stroke 2004, 35:496–501.

    Article  PubMed  Google Scholar 

  6. Lindsberg P, Grau AJ: Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34:2518–2532. Extensively reviews the present knowledge on the association between infection, inflammation, and stroke.

    Article  PubMed  Google Scholar 

  7. Pussinen PJ, Alfthan G, Rissanen H, et al.: Antibodies to periodontal pathogens and stroke risk. Stroke 2004, 35:2020–2023.

    Article  PubMed  Google Scholar 

  8. Greenwell H, Bissada NF: Emerging concepts in periodontal therapy. Drugs 2002, 62:2581–2587.

    Article  PubMed  CAS  Google Scholar 

  9. Grayston JT: Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000, 181:S402-S410.

    Article  PubMed  CAS  Google Scholar 

  10. Apfalter P, Barousch W, Nehr M, et al.: No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction. Stroke 2004, 35:2024–2028.

    Article  PubMed  CAS  Google Scholar 

  11. Johnston SC, Messina LM, Browner WS, et al.: C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 2001, 32:2748–2752.

    PubMed  CAS  Google Scholar 

  12. Vainas T, Kurvers AJM, Mess WH, et al.: Chlamydia pneumoniae serology is associated with thrombosisrelated but not with plaque-related microembolization during carotid endarterectomy. Stroke 2002, 33:1249–1254.

    Article  PubMed  Google Scholar 

  13. LaBiche R, Koziol D, Quinn TC, et al.: Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001, 32:855–860.

    PubMed  CAS  Google Scholar 

  14. Etminan M, Carleton B, Delaney JA, Padwal R: Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials. Pharmacotherapy 2004, 24:338–343.

    Article  PubMed  CAS  Google Scholar 

  15. ÓConnor CM, Dunne MW, Pfeffer MA, et al.: Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 2003, 290:1459–1466.

    Article  Google Scholar 

  16. Sander D, Winbeck K, Klingelhöfer J, et al.: Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation 2004, 109:1010–1015.

    Article  PubMed  CAS  Google Scholar 

  17. Gieffers J, Fullgraf H, Jahn J, et al.: Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001, 103:351–356.

    PubMed  CAS  Google Scholar 

  18. Pietroiusti A, Diomedi M, Silvestrini M, et al.: Cytotoxin-associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002, 106:580–584.

    Article  PubMed  CAS  Google Scholar 

  19. Preusch MR, Grau AJ, Buggle F, et al.: Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Stroke 2004, 35:1800–1804.

    Article  PubMed  CAS  Google Scholar 

  20. Cremonini F, Gabrielli M, Gasbarrini G, et al.: The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis. Atherosclerosis 2004, 173:253–259.

    Article  PubMed  CAS  Google Scholar 

  21. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al.: Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002, 105:15–21.

    Article  PubMed  Google Scholar 

  22. Kiechl S, Egger G, Mayr M, et al.: Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study. Circulation 2001, 103:1064–1070.

    PubMed  CAS  Google Scholar 

  23. Grau AJ, Boddy AW, Dukovic DA, et al.: The leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004, 35:1137–1142.

    Google Scholar 

  24. Di Napoli M, Papa F: Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 2002, 33:1763–1771.

    Article  PubMed  Google Scholar 

  25. Ridker PM, Rifai N, Clearfield M, et al.: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001, 344:1959–1965.

    Article  PubMed  CAS  Google Scholar 

  26. Nicholson KG, Wood JM, Zambon M: Influenza. N Engl J Med 2003, 362:1733–1745.

    CAS  Google Scholar 

  27. Nichol KL, Nordin J, Mullooly J, et al.: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348:1322–1332. This is the largest observational study on influenza vaccination and risk of hospitalization for cardiovascular and cerebrovascular diseases so far.

    Article  PubMed  Google Scholar 

  28. Lavallée P, Perchaud V, Gautier-Bertrand M, et al.: Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002, 33:513–518.

    Article  PubMed  Google Scholar 

  29. Gurfinkel EP, de la Fuente L, Mendiz O, Mautner B: Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002, 105:2143–2147.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Klinikum der Stadt Ludwigshafen a. Rhein, Bremserstr. 70, 67063, Ludwigshafen am Rhein, Germany

    Armin J. Grau MD, PhD

Authors
  1. Armin J. Grau MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grau, A.J. Role of anti-infective strategies in the prevention of stroke. Curr Treat Options Cardio Med 7, 187–195 (2005). https://doi.org/10.1007/s11936-005-0047-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-005-0047-6

Keywords

Search

Navigation